Objective: This study aimed to reveal the associations between the risk of new-onset type 2 diabetes and the duration of antidepressant use and the antidepressant dose, and between antidepressant use after diabetes onset and clinical outcomes.
Research design and methods: In this large-scale retrospective cohort study in Japan, new users of antidepressants (exposure group) and nonusers (nonexposure group), aged 20-79 years, were included between 1 April 2006 and 31 May 2015. Patients with a history of diabetes or receipt of antidiabetes treatment were excluded. Covariates were adjusted by using propensity score matching; the associations were analyzed between risk of new-onset type 2 diabetes and the duration of antidepressant use/dose of antidepressant in the exposure and nonexposure groups by using Cox proportional hazards models. Changes in glycated hemoglobin (HbA1c) level were examined in groups with continuous use, discontinuation, or a reduction in the dose of antidepressants.
Results: Of 90,530 subjects, 45,265 were in both the exposure and the nonexposure group after propensity score matching; 5,225 patients (5.8%) developed diabetes. Antidepressant use was associated with the risk of diabetes onset in a time- and dose-dependent manner. The adjusted hazard ratio was 1.27 (95% CI 1.16-1.39) for short-term low-dose and 3.95 (95% CI 3.31-4.72) for long-term high-dose antidepressant use. HbA1c levels were lower in patients who discontinued or reduced the dose of antidepressants (F[2,49] = 8.17; P < 0.001).
Conclusions: Long-term antidepressant use increased the risk of type 2 diabetes onset in a time- and dose-dependent manner. Glucose tolerance improved when antidepressants were discontinued or the dose was reduced after diabetes onset.
© 2020 by the American Diabetes Association.
Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.JAMA Pediatr. 2017 Dec 1;171(12):1200-1207. doi: 10.1001/jamapediatrics.2017.2896. JAMA Pediatr. 2017. PMID: 29049533 Free PMC article.
Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.Int J Epidemiol. 2015 Dec;44(6):1927-40. doi: 10.1093/ije/dyv153. Epub 2015 Aug 4. Int J Epidemiol. 2015. PMID: 26245205 Clinical Trial.
Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.Br J Clin Pharmacol. 2008 Apr;65(4):558-64. doi: 10.1111/j.1365-2125.2007.03052.x. Epub 2007 Dec 7. Br J Clin Pharmacol. 2008. PMID: 18070221 Free PMC article.
Psychological therapies for treatment-resistant depression in adults.Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2. Cochrane Database Syst Rev. 2018. PMID: 29761488 Free PMC article. Review.
Antidepressants for people with epilepsy and depression.Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Cochrane Database Syst Rev. 2014. PMID: 25464360 Free PMC article. Review.